Director, Statistician Real-World Analytics
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
The Director Statistician Real‑World Analytics will provide statistical leadership for real-world evidence (RWE), epidemiology, health economics and outcomes research (HEOR) studies supporting Revolution Medicines' oncology development programs.
This individual will serve as the statistical lead for observational research studies across the drug development lifecycle, partnering closely with HEOR/RWE scientists, real-world analytics programmers, clinical development, medical affairs, regulatory
